ETOPOSIDE – etoposide 20 mg/mL intravenous solution

Meitheal Pharmaceuticals

neuroblastoma; acute myeloid leukemia; Kaposi’s sarcoma; conditioning prior to allogeneic stem cell transplant; Burkitt’s lymphoma; ovarian germ cell tumor carcinoma; small cell lung carcinoma; progressive diffuse large B-cell lymphoma; non-small cell lung cancer; refractory malignant tumor of testis; Hodgkin’s lymphoma; osteosarcoma of bone; testicular germ cell tumor; Ewing’s sarcoma; malignancy; neuroendocrine prostate carcinoma; diffuse large B-cell lymphoma; multiple myeloma

diffuse large B-cell lymphoma; Kaposi’s sarcoma; neuroblastoma; testicular germ cell tumor; acute myeloid leukemia; refractory malignant tumor of testis; malignancy; progressive diffuse large B-cell lymphoma; non-small cell lung cancer; Hodgkin’s lymphoma; neuroendocrine prostate carcinoma; ovarian germ cell tumor carcinoma; small cell lung carcinoma; Ewing’s sarcoma; conditioning prior to allogeneic stem cell transplant; Burkitt’s lymphoma; multiple myeloma; osteosarcoma of bone

Controlled Room Temp (20-25°C)